Showing results 8 to 27 of 28
< previous
next >
| Issue Date | Title | Author(s) |
| 2018-05-23 | Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell Death | Koolaji, N; Rawling, T; Bourget, K; Murray, M |
| 2021-02-16 | Chapter 3 Sustainable origin-sorbents for heavy metal contamination: Research progress within an Australian context | Murray, M; Bugdayli, K |
| 2021-04-01 | Complex soil contamination severely impacts seed-sown crop viability in Australia | McDonald, A; Murray, B; Krix, D; Murray, M |
| 2018-03-01 | Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver | Murray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T |
| 2021-02-05 | Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite. | Nair, PC; Gillani, TB; Rawling, T; Murray, M |
| 2010-02-01 | Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: Monounsaturated omega-3 fatty acids | Rawling, T; Duke, CC; Cui, PH; Murray, M |
| 2023-01-15 | Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids. | Rahman, MK; Umashankar, B; Choucair, H; Pazderka, C; Bourget, K; Chen, Y; Dunstan, CR; Rawling, T; Murray, M |
| 2019-11-01 | Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib | Murray, M; Gillani, TB; Rawling, T; Nair, PC |
| 2018-10-13 | Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivatives | Pereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F |
| 2017-10-26 | A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin to Promote Killing of Breast Cancer Cells | Rawling, T; Choucair, H; Koolaji, N; Bourget, K; Allison, SE; Chen, YJ; Dunstan, CR; Murray, M |
| 2017-01-01 | A novel synthetic analogue of v-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ ASK1/JNK signaling to promote apoptosis in human breast cancer cells | Dyari, HRE; Rawling, T; Chen, Y; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M |
| 2020 | Omega-3 Polyunsaturated Fatty Acid Derived Lipid Mediators and Their Application in Drug Discovery. | Pazderka, CW; Oliver, B; Murray, M; Rawling, T |
| 1991-01-01 | Photosynthetic and stomatal conductance responses of Norway spruce and beech to ozone, acid mist and frost-a conceptual model | Eamus, D; Murray, M |
| 2023-12-21 | Protonophoric and mitochondrial uncoupling activity of aryl-carbamate substituted fatty acids. | MacDermott-Opeskin, H; Clarke, C; Wu, X; Roseblade, A; York, E; Pacchini, E; Roy, R; Cranfield, C; Gale, PA; O'Mara, ML; Murray, M; Rawling, T |
| 2021-10 | PTU, a novel ureido-fatty acid, inhibits MDA-MB-231 cell invasion and dissemination by modulating Wnt5a secretion and cytoskeletal signaling. | Al-Zubaidi, Y; Chen, Y; Khalilur Rahman, M; Umashankar, B; Choucair, H; Bourget, K; Chung, L; Qi, Y; Witting, PK; Anderson, RL; O'Neill, GM; Dunstan, CR; Rawling, T; Murray, M |
| 2012-07-15 | Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites | Ghassabian, S; Rawling, T; Zhou, F; Doddareddy, MR; Tattam, BN; Hibbs, DE; Edwards, RJ; Cui, PH; Murray, M |
| 2014-11-01 | Selective inhibition of human solute carrier transporters by multikinase inhibitors | Johnston, RA; Rawling, T; Chan, T; Zhou, F; Murray, M |
| 2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |
| 2023-08-30 | Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG. | Loo, S; Roberts, AW; Anstee, NS; Kennedy, GA; He, SZ-X; Schwarer, AP; Enjeti, AK; D'Rozario, J; Marlton, P; Bilmon, I; Taper, JM; Cull, G; Tiley, C; Verner, E; Hahn, U; Hiwase, DK; Iland, HJ; Murphy, NE; Ramanathan, S; Reynolds, J; Ong, DM; Tiong, IS; Wall, M; Murray, M; Rawling, T; Leadbetter, J; Rowley, L; Latimer, M; Yuen, SLS; Ting, SB; Fong, CY; Morris, KL; Bajel, A; Seymour, JF; Levis, MJ; Wei, AH |
| 2012-07-29 | Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: Kinetics and application | Rawling, T; McDonagh, AM; Tattam, B; Murray, M |
